Inhibitors | Comment | Organism | Structure |
---|---|---|---|
additional information | activation of EphB2 receptor kinase arrests tau hyperphosphorylation through PI3K-/Akt-mediated GSK-3beta inhibition. EphrinB1/Fc treatment induces tyrosine phosphorylation (activation) of EphB2, while deletion of the tyrosine kinase domain (VM) of EphB2 eliminates the receptor stimulation-induced GSK-3beta inhibition and tau dephosphorylation | Homo sapiens | |
additional information | stimulation of EphB2 upregulates PI3K and Akt causing inhibition of GSK-3beta | Mus musculus |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Homo sapiens | |
Mg2+ | required | Mus musculus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [tau-protein] | Homo sapiens | - |
ADP + O-phospho-[tau-protein] | - |
? | |
ATP + [tau-protein] | Mus musculus | recombinant human tau protein expressed in transgenic mice | ADP + O-phospho-[tau-protein] | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P49841 | - |
- |
Mus musculus | Q9WV60 | human tau transgenic mice Thr231 | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | the active form of GSK-3beta is co-localized with the neurofibrillary tangles in the Alzheimer disease brains | Homo sapiens | - |
brain | the active form of GSK-3beta is co-localized with the neurofibrillary tangles in the Alzheimer disease brains | Mus musculus | - |
hippocampus | - |
Homo sapiens | - |
hippocampus | - |
Mus musculus | - |
neuron | - |
Homo sapiens | - |
neuron | - |
Mus musculus | - |
SK-N-SH cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [tau-protein] | - |
Homo sapiens | ADP + O-phospho-[tau-protein] | - |
? | |
ATP + [tau-protein] | recombinant human tau protein expressed in transgenic mice | Mus musculus | ADP + O-phospho-[tau-protein] | - |
? | |
ATP + [tau-protein] | phosphorylation level of tau at Thr205, Thr231, Ser396 and tau-1 sites | Homo sapiens | ADP + O-phospho-[tau-protein] | - |
? | |
ATP + [tau-protein] | phosphorylation level of tau at Thr205, Thr231, Ser396 and tau-1 sites | Mus musculus | ADP + O-phospho-[tau-protein] | - |
? |
Synonyms | Comment | Organism |
---|---|---|
GSK-3beta | - |
Homo sapiens |
GSK-3beta | - |
Mus musculus |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Homo sapiens | |
ATP | - |
Mus musculus |
General Information | Comment | Organism |
---|---|---|
malfunction | Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3beta | Homo sapiens |
malfunction | Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3beta | Mus musculus |
physiological function | stimulation of GSK-3beta both in vitro and in vivo induces tau hyperphosphorylation with impairments of the cognitive functions, whereas inhibition of GSK-3beta improves tau pathologies and memory deficits. Activation of EphB2 receptor kinase arrests tau hyperphosphorylation through PI3K-/Akt-mediated GSK-3beta inhibition. Activation of GSK-3beta inhibits long-term potentiation and impairs synaptic function | Homo sapiens |
physiological function | stimulation of GSK-3beta both in vitro and in vivo induces tau hyperphosphorylation with impairments of the cognitive functions, whereas inhibition of GSK-3beta improves tau pathologies and memory deficits. Stimulation of EphB2 upregulates PI3K and Akt with inhibition of GSK-3beta. Stimulation of EphB2 attenuates tau phosphorylation both in vitro and in hippocampus of human tau transgenic mice | Mus musculus |